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a b s t r a c t
Polycomb ring ﬁnger oncogene BMI1 (B cell-speciﬁc Moloney murine leukemia virus integration site 1)
plays a critical role in development of several types of cancers. Here, we report an inverse relationship
between levels of BMI1 expression and adenovirus (Ad) progeny production. Enforced BMI1 expression
in A549 cells impaired Ad progeny production. In contrast, knocking-down of endogenous BMI1
expression enhanced progeny production of a conditionally replicating Ad and wild-type Ad5 and
Ad11p. Ad vectors overexpressing BMI1 were not impaired in the replication of progeny genomes and in
the expression of E1A and Ad structural proteins. However, 293 cells infected by Ad vector over-
expressing BMI1 contained a large proportion of morphologically irregular Ad particles. This effect was
reversed in 293 cells pre-treated with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) in
parallel with the production of infectious Ad particles. Our ﬁndings suggest an inhibitory role of BMI1 in
Ad morphogenesis that can be implied in Ad tropism and Ad-mediated cancer therapy.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Adenovirus (Ad) infection is common in all human populations.
Ads have increasingly been recognized as signiﬁcant viral pathogens,
with high morbidity and mortality, particularly among immunologi-
cally compromised patients (Echavarria, 2008). Fifty-seven known
serotypes of human Ads have hitherto been identiﬁed. Ad infection
is associated with stereotypically distinctive clinical manifestations, for
example, the upper respiratory tract infection in young children is
caused by the group C Ad1, Ad2, and Ad5; epidemic keratoconjuncti-
vitis is caused by the group D Ad8, Ad19, and Ad37; and hemorrhagic
cystitis is due to group B Ad11, Ad34, and Ad35 infections. Generally,
infections of other serotypes are often self-limiting and subclinical, but
species B Ads such as Ad3, Ad7, Ad11, and Ad14 can cause life-
threatening infection (Gerber et al., 2001; Metzgar et al., 2007). And
persistent infection by species C Ad is often observed in children (Fox
et al., 1969, 1977). The virulence factors causing the varying clinical
manifestations of different Ad serotypes are not well understood.
Ad replication and propagation, and likely the virulence factors
of the different Ad serotypes, are dependent on interplay between
Ad and host cells at various stages of Ad life cycle. The interaction
between host cell surface receptor and Ad capsid ﬁber molecules
or the complexes of ﬁber-penton base comprises the ﬁrst deter-
mining step whether or not an Ad particle can bind to and
subsequently enter a given cell type. in vitro studies have shown
that most Ad serotypes utilize the coxsackie adenovirus receptor
(CAR) as the primary attachment receptor. These Ads preferentially
infect cells of epithelial origin (Bergelson et al., 1997; Roelvink et
al., 1998). Generally, a subgroup of type B Ads utilizing the cell
surface receptor CD46 are associated with a broad tropism (Gaggar
et al., 2003; Marttila et al., 2005), but the more pathogenic subset
including Ad3, Ad7, Ad11, and Ad14 utilizes Desmoglein 2 to
initiate infection (Wang et al., 2011). GD1a glycan molecules serve
as a receptor for the Ad serotypes responsible for causing epidemic
keratoconjunctivitis (Nilsson et al., 2011).
Early in the Ad life cycle, Ad E1A protein forces host cells into
the S phase, so that the host cells are hijacked to serve as a factory
to synthesize large amounts of viral proteins and genomes for viral
replication (Berk, 2005). This abnormal stimulation of cell cycle
and E1A activation leads to stabilization of p53, which in turn
induces the apoptosis process. E1B-55K and E1B-19K proteins
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inhibit the apoptosis by ubiquitin-dependent degradation of p53,
and sequestering pro-apoptotic BAK and BAX molecules, respec-
tively (Berk, 2005). The host cell synthesis of large amounts of
interferon molecules that inhibit adenoviral life cycle is counter-
acted by E1A protein (Gutch and Reich, 1991).
Later in the Ad life cycle, the Ad structural proteins hexon,
penton base and ﬁber molecules are produced in high abundance.
The penton base and ﬁber molecules are released in excess from
the infected host cells, which subsequently bind to Ad receptors on
the surrounding cells (Fender et al., 1997; Rebetz et al., 2009;
Trotman et al., 2003; Walters et al., 2002; Wang et al., 2011). This
binding is suggested to promote Ad spread and to regulate the
equilibrium between Ad propagation and host cell survival (Rebetz
et al., 2009; Walters et al., 2002). Within the infected cells,
structural proteins form adenoviral capsids that are transported
into the nucleus, where the Ad genomes condensed with proteins
VII and V are injected into the preformed capsids, resulting in the
formation of mature viruses. The packing processes and its
regulation and maturation of Ad particles are hitherto poorly
understood (Giberson et al., 2012).
Here, we report that BMI1 (B cell-speciﬁc Moloney murine
leukemia virus integration site 1), a polycomb gene previously
known as a stem cell gene (Lessard and Sauvageau, 2003;
Molofsky et al., 2003) and oncogene (van Lohuizen et al., 1991),
inhibits Ad progeny production. Recombinant Ad vector over-
expressing BMI1 could not be generated at the same efﬁciency as
the other Ad vectors. siRNA mediated knocking-down of endo-
genous BMI1 expression in host cells enhanced the production
of a telomerase activity-controlled conditionally replicating Ad
(Ad-CRAD), wild-type Ad5 and Ad11p, whereas retroviral vector
mediated enhanced expression of BMI1 in host cells suppressed
Ad production. Our characterization of Ad genome replication, Ad
structural protein synthesis and electron microscopy analysis of Ad
particles in situ in infected 293 cells demonstrated that BMI1
impaired the maturation of Ad particles but did not cause any
measurable effects on Ad structural protein production and Ad
genome replication, and this effect was reversed by histone
deacetylase (HDAC) inhibitor trichostatin (TSA). These ﬁndings
suggest that BMI1 related HDAC activity constitutes an intrinsic
defense mechanism against Ad infection in cells, which may have
implications in Ad tropism and in the engineering of Ad as cancer
therapy agents.
Results
Deﬁciency in generating Ad vectors encoding BMI1
As a member of the polycomb complex 1, BMI1 has been
demonstrated to play a critical in the self-renewal of adult stem
cells (Lessard and Sauvageau, 2003; Molofsky et al., 2003). Our
initial goal was to transiently overexpress BMI1 in primitive
hematopoietic progenitors (Jaras et al., 2007). Based on our
previous studies that bi-directional PGK promoter allowed higher
level of dual gene expression compared to bicistronic expression
cassette under the control of non-modiﬁed PGK promoter (Na and
Fan, 2010), we engineered two Ad vector constructs encoding
BMI1 (Fig. 1A). Viruses were rescued with the bicistronic expres-
sion cassette controlled by the non-modiﬁed PGK promoter (the
BIG construct). However, multiple attempts to rescue the dual
gene expression cassette controlled by the bi-directional PGK
promoter (the mBmi1-BiDp-GFP construct) failed. The BIG vector
and the control LIG vector encodingΔLNGFR and GFP (Na and Fan,
2010) were expanded and puriﬁed under the same conditions. The
BIG vector preparation contained signiﬁcantly fewer infectious
viral particles compared to the LIG vector preparation. At the same
doses of OD260 optical units (OPU) per cell, infection of 293 cells
with BIG vector preparation resulted in less than one ﬁfth of GFP-
positive cells compared to the control LIG vector preparation
(Fig. 1B). Limiting dilution assessment of GFP Infection Units
Fig. 1. Generation and characterization of Ad vectors encoding BMI1. (A) Depiction of adenoviral constructs encoding BMI1 and the control ΔLNGFR-IRES-GFP (LIG) vector
construct. Viruses were rescued with the mBmi1-IRES-GFP (BIG) construct encoding BMI1 and GFP controlled by PGK promoter, but not with the mBmi1-BiDp-GFP construct
by bi-directional PGK-minCMV promoter. BIG and LIG were used to infect 293 cells (B) and A549 cells (C). The extent of GFP expression was assessed by FACS at 48 h post-
infection. Representative histograms showing that BIG preparation contained fewer infectious viral particles.
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(GIU) showed that compared to the control LIG vector preparation,
the BIG vector preparation was reduced to less than one seventh
infectious viral particles (Table 1). Measurable frequencies of GFP-
positive cells were not detected in A549 cell cultures infected
with BIG preparation at doses up to 1500 OPU/cell (Fig. 1C); 10 to
15-fold more OPUs of BIG preparation in comparison to LIG
preparation were required for comparable levels of GFP expression.
We also assessed whether polycomb genes are in general not
compatible with Ad vector generation. Ad vector encoding EZH2, a
member of the polycomb complex 2, was also produced at the titer
comparable to that of the other Ad vector preparations under our
conditions. Further, to the best of our knowledge, successful
generation of Ad vectors encoding BMI1 has hitherto not been
reported. These data together suggest an incompatibility between
the overexpression of BMI1 and Ad vector generation.
Inverse correlation between Ad progeny production and the level
of BMI1 expression in host cells
To study whether endogenous BMI1 expression in host cells
could affect Ad replication, we ﬁrst studied the effect of an
enforced BMI1 expression on Ad replication. A549 cells stably
infected with VSV-G pseudotyped retroviral vectors encoding
BMI1 or GFP were generated. These cells were then infected by a
telomerase activity-controlled, conditionally replicating Ad5 virus
encoding GFP in the E1B region (Ad5-CRAD, (Rebetz et al., 2009))
at 200 OPU/cell, the whole cultures were harvested at 24 h post-
infection, and used to infect non-modiﬁed A549 cells. At 24 h after
the second round of infection, and the percentages of GFP-positive
cells were determined. Enforced BMI1 expression signiﬁcantly
impaired Ad production, progeny viruses generated from
100 000 control or BMI1 overexpressing cells were sufﬁcient to
infect 86.574.8% and 45.673.6% (n¼3, po0.001) of the cells in
the second round infection, respectively (Fig. 2A).
Next we examined the consequence of knocking-down BMI1
expression in A549 cells on Ad progeny production. A549 cells
were stably transduced by pSuper-retroviral vectors encoding
siRNA constructs against BMI1 or GFP. Following selection by
puromycin, real-time RT-PCR assay using two different sets of
primers demonstrated a 50% reduction of BMI1 expression in
cells transduced with siRNA constructs against BMI1 compared to
control cells transduced with siRNA construct against GFP
(Fig. 4A). The two-round infection strategy as described above
was used to assess the progeny production of Ad5-CRAD. Progeny
viruses generated from 150 000 control cells or BMI1 knockdown
cells with were sufﬁcient to infect 12.871.0% and 25.371.6%
(n¼3, po0.001) cells in the second round infection, respectively
(Fig. 2B). We also investigated the effect of BMI1 knockdown in
successive rounds of adenoviral propagation. At one-week post
infection with 1 and 10 OPU/cell of Ad5-CRAD, 1.8 to 1.4-fold more
GFP-positive cells were detected in BMI1 knockdown A549 cells
compared to the control A549 cells, respectively (data not shown).
We further assessed the effect on production of wild type Ad5
and Ad11p in BMI1 knockdown A549 cells. Infected cells were
detected by intracellular staining of hexon expression in ﬂow
cytometry. Using the two-round infection strategy as above,
progenies of Ad5 infection in 150 000 control cells or cells with
knocking-down of BMI1 were sufﬁcient to infect 26.973.8% and
39.971.0% (n¼3, po0.001) cells in the second round infection,
respectively (Fig. 2C). A similarly signiﬁcant trend of enhanced
Ad11p production was observed in BMI1 knockdown cells
(Fig. 2D). These data together demonstrate that BMI1 expression
in host cells can inhibit Ad progeny production.
Effects on cell cycle progression and Ad infectivity in host cells
following manipulation of BMI1 expression
The inverse relationship between Ad progeny production and
BMI1 expression can potentially be caused by an effect of BMI1 on
the cell cycle progression and/or host cell infectivity towards Ad.
To characterize the inhibitory effect of BMI1 on adenoviral progeny
production, we ﬁrst assessed the effect of cell proliferation in BMI1
knockdown cells. As assessed using BrdU labeling assay, 37% of
the cells were found in the S-phase of cell cycle, both in BMI1
knockdown A549 cells and in the control A549 cells. No measur-
able effects were found on cell proliferation as assessed by MTS
assays (Fig. 3A). Further, we assessed the expression of CAR and
CD46 by FACS. No measurable difference in the expression of CAR
or CD46 was found between A549 cells with or without knocking-
down of BMI1 (Fig. 3B). These cells also showed comparable
infectivity towards Ad5F35-ΔLNGFR-BiDp-GFP and Ad5F35-PGK-
GFP vectors (utilizing CD46 as primary attachment receptor), and
Ad5-PGK-GFP vector (utilizing CAR as receptor) (Fig. 3C). Thus, the
cell cycle progression and Ad infectivity in host cells are unlikely
affected by the extent of BMI1 expression.
Effects of BMI1 expression on Ad life cycle
To assess the potential effects of BMI1 on adenoviral life cycle,
we ﬁrst quantiﬁed the mRNA transcripts of E1A by real-time
RT-PCR at 6 h post-infection with Ad5-CRAD. A marginal, but not
signiﬁcant, reduction of E1A mRNA expression was detected in
BMI1 knockdown A549 cells compared to the control cells
(Fig. 4A). Similar trends were observed at 20 h post-infection for
the structural protein hexon and the 100 K protein that regulates
the assembly of hexon trimers and the preferential translation of
viral mRNAs (Morin and Boulanger, 1986; Xi et al., 2004).
We found that the production of BIG vector was signiﬁcantly
improved in 293 cells pre-treated with the HDAC inhibitor TSA
(detailed below). Using such BIG preparations, we further character-
ized the deﬁciency of BIG progeny production in 293 cells. Compared
to the control LIG vector, the progeny production was markedly
impaired in 293 cells infected with the BIG vector preparation, as
demonstrated by the reduced percentage of GFP-positive cells and the
extent of GFP expression both in the ﬁrst round infection following the
infection with BIG vector preparation (Fig. 4B), and in the second
round infection using the cell lysate from the ﬁrst round infection
(Fig. 4C). In Ad5 infection, ﬁber molecules are produced in an excess
and secreted prior to the release of progeny (Rebetz et al., 2009). Host
cell surface binding of ﬁber molecules was detected in all cells infected
by the BIG vector (Fig. 4B), indicating that the progression into the late
stages of Ad life cycle was not signiﬁcantly impaired following BIG
vector infection of 293 cells. Using SDS-PAGE and Western-blot, we
separated the total lysate of the infected cells at the manifestation of
cytopathic effect. There was no detectable difference observed in the
production of Ad structural proteins hexon, penton base and ﬁber
proteins was observed between the cells infected by BIG or LIG
(Fig. 4D). Using real-time PCR measurement of the copy numbers of
Ad genome at 4 and 24 h post-infection, we assessed the expansion of
Ad genomes. The results showed that compared to the control LIG
Table 1
BIG vector preparation contained fewer infectious viral particles.
Optical particle units (OPU) GFP infection units (GIU) OPU/GIU
BIG 5.941011 OPU/ml 5.79108 GIU/ml 1027/1
LIG 4.951011 OPU/ml 3.6109 GIU/ml 137/1
T-BIG 1.41012 OPU/ml 1.0721010 GIU/ml 131/1
Each vector preparation was measured for their content of optical particle units
(OPU) at OD260 and GFP infectious viral viral particle units (GIU) in 293 cells using
limiting dilution assay. T-BIG denotes BIG vector preparation expanded in 293 cells
pre-treated with TSA at 50 ng/ml.
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Fig. 2. Inverse correlation between Ad progeny production and BMI1 expression in A549 cells. (A) Inhibition of Ad progeny production by enforced BMI1 expression. A549 cells stably
transduced by retroviral vectors encoding BMI1 or GFP were infected by Ad5-CRAD at 200 OPU/cell and harvested at 24 h post-infection. The lysate corresponding to 1105 cells were
used to infect non-modiﬁed A549 cells. Representative histograms (left panel) and the averages and standard deviations (right panel) of the percentages of GFP-positive cells (n¼3) at
24 h post the second round of infection were shown. (B), (C), (D) Enhanced adenoviral progeny production by knocking-down of endogenous BMI1 expression. A549 cells stably
transduced with retroviral siRNA construct against BMI1 or GFP were infected with Ad5-CARD (B), wild type Ad5 (C) or Ad11p (D) at 100 OPU/cell. Cultures were harvested at 24 h
post-infection and progenies in 1.5105 cells were used to infect non-modiﬁed A549 cells. Representative histograms (left panels) and the averages and standard deviations (right
panels) of the percentages (n¼3) of the cells infected by the progeny viruses as detected by GFP intensity for Ad5-CARD, or by hexon staining for Ad5 or Ad11p at 24 h of the second
round infection are shown. Student's t-test is used for the statistic analysis in those experiments.
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Fig. 3. No detectable effects of cell cycle progression and Ad infectivity in A549 cells with knocking-down of BMI1 expression. (A) No measurable effects of cell cycle status
by knocking-down of BMI1 expression. Left panel: A549 cells stably transduced with siRNA construct against BMI1 or GFP were cultured with BrdU at 10 μM for 60 min. Cells
labeled by BrdU were detected in ﬂow cytometry. Right panel: parallel cultures measured for cell proliferation in MTS assay. (B) Comparable levels of CAR and CD46
expression in A549 cells with or without knocking-down of BMI1 expression as detected in ﬂow cytometry. (C) A549 cells stably transduced with siRNA construct against
BMI1 or GFP showed comparable infectivity by Ad5F35-ΔLNGFR-BiDp-GFP (upper panels), Ad5F35-PGK-GFP (lower left panel) or Ad5-PGK-GFP (lower right panel) vectors.
A549 cells with or without knocking-down of BMI1 expression were infected with the indicated vectors at 100 OPU/cell, the transgene expression was detected at 24 h post
infection. Representative histograms are shown. The expression of siRNA construct against GFP mRNA resulted in diminished extent of GFP expression compared to cells
expressing siRNA construct against BMI1.
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Fig. 4. Abundant productions of Ad structural proteins and Ad genome in A549 cells with knocking-down of BMI1 expression. (A) Real-time RT-PCRmeasures the mRNA abundance of
BMI1, E1A, hexon and 100 K in A549 cells with siRNA knocking-down of BMI1 or GFP at 6 h (BMI1 and E1A) or 20 h (hexon and 100 K) post infection of Ad5-CRAD at 200 OUP/cell. BMI
expression was down-regulated by siRNA in A549-siBMI1 cells (n¼3, student's t-test). No signiﬁcant difference in mRNA abundances of E1A, hexon and 100 K was detected between
cells with or without knocking-down of BMI1 expression. The p values were obtained by a paired t-test. (B), (C) and (D) Assessment of progeny production and structural protein
production following BIG vector infection of 293 cells. (B) BIG vectors expanded in TSA treated 293 cells were used to infect 293 cells at 100 OPU/cell in comparisonwith the LIG vector.
At 24 h post infection, cells weremeasured in ﬂow cytometry for GFP expression and binding of ﬁber molecules on cell surface. The numbers in each quadrat represent the percentages
of the cells with GFP expression and cell surface ﬁber binding in the corresponding quadrat. (C) lysis of the indicated volumes of the parallel cultures as in (B) were used to infect 293
cells. GFP expression was measured at 24 h post infection. The data demonstrate diminished progeny production of BIG vector. (D) Left panel: Western-blot analysis of hexon, penton
base and ﬁber proteins in 293 cells at 24 h post infection of BIG (expanded in TSA pre-treated 293 cells) or LIG vector at 100 OPU/cell. Right panel: lysate of the infected cells at the
manifestation of cytopathic effect were separated using SDS-PAGE and stained with Coomassie blue. The data show structural proteins were abundantly produced in BIG infected cells.
(E) Left panel: Real-time PCR assessment of the expansion of BIG and LIG vector genome in 293 cells. 293 cells were infected by BIG (expanded in TSA treated 293 cells) or LIG vector at
100 OPU/cell. Cells were washed at 4 h post infection. The copy number of Ad genome was measured at 4 and 24 h post infection. Right panel: DNA samples from cells infected with
the indicated vectors at the manifestation of cytopathic effect were extracted and digested with HindIII and separated in 0.8% agarose gel. The data show the vector genomes were
abundantly produced in the BIG infected cells.
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vector, the replication of BIG vector genomes was not measurably
affected (Fig. 4E). Further, complete genome molecules for the BIG
vector were indeed produced at the levels comparable to the LIG
vector, as demonstrated by the HindIII digest of the episomal DNA
extracted from the infected cells at the manifestation of cytopathic
effect.
These data together indicate that host cell infectivity by Ad vector
and progression of Ad life cycle was unlikely affected by BMI1. The fact
that Ad genomes and structure proteins in BIG-infected 293 cells were
produced at levels comparable to LIG infected 293 cells, but functional
progenies were generated to a signiﬁcantly less extent in BIG-infected
293 cells, suggests impairment in the assembly of viral particles.
Involvement of HDAC activity in BMI1 mediated inhibition of
adenoviral production
BMI1 can directly interact with HDAC in polycomb complexes
(Xia et al., 2003). BMI1 can be transcriptionally regulated by HDAC
Fig. 5. Impaired morphogenesis of BIG vector in 293 cells and its reversion by TSA treatment. Improved production of BIG vector as assessed in transduction assay in A549
cells (A) and electron microscopy analysis (B) with BIG vector preparations expanded in 293 cells pre-treated with TSA. O-BIG and T-BIG indicate BIG vector preparations
expanded in 293 cell cultures without or with TSA pre-treatment. (C) Electron microscopy analyzes BIG vector expansion in situ in 293 cells with or without TSA treatment.
293 cells with or without TSA pre-treatment were infected with BIG vector preparation at 200 OPU/cell. At 24 h post infection, cells were examined in electron microscopy
following ﬁxation, ultrathin section and negative staining. Representative nuclei are shown. The labeled areas in the upper panels (scale bars are 0.5 μm) are enlarged in the
lower panels (scale bars are 0.2 μm). The majority of the electron-dense BIG particles in 293 cells without TSA pre-treatment showed irregular morphology.
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(Bommi et al., 2010). To identify mechanisms of BMI1 mediated
detrimental effects on Ad progeny production, we expanded BIG
vector in 293 cell cultures pre-treated with the HDAC inhibitor
TSA. Because previous studies have indicated that polycomb gene
can control DNA methylation (Vire et al., 2006), we also expanded
BIG vector in 293 cell cultures pre-treated with DNA methylation
inhibitor 5-Aza-20-deoxycytidine (5-AZa) or Zebularine. TSA treat-
ment, but not inhibition of DNA methylation, signiﬁcantly
improved the BIG vector production. The OPU versus GIU ratios
in two BIG preparations expanded with TSA treated 293 cell
cultures (T-BIG preparations) were 155:1 and 130:1, respectively
(Table 1), which was comparable to the production of other
vectors. The infection efﬁciency of these BIG vector preparations
in A549 cells appeared slightly lower compared to the control LIG
vector preparation (Fig. 5A). As examined in electron microscopy,
the density of mature-looking BIG particles in the preparations
expanded from TSA treated 293 cultures was markedly increased
compared to the preparations expanded 293 cultures without TSA
treatment (Fig. 5B).
To further evaluate the effect of TSA on BIG vector production,
TSA-treated 293 cells were examined in electron microscope at 24 h
post-infection with T-BIG preparation at 200 OPU/cell. The TSA
treated cells contained higher numbers of mature Ad particles
compared to the cells not treated with TSA. Of note, the electron-
dense BIG particles in the nuclei of TSA-treated 293 cells showed
regular icosahedral morphology. In contrast, a substantial fraction of
electron-dense BIG particles in the nuclei of 293 cells without TSA
treatment showed irregular morphology (Fig. 5C). These data
together indicate that high-level BMI1 expression resulted in a
deﬁciency in the late stage of Ad morphogenesis, and that the HDAC
inhibitor TSA counteracted the BMI1-related detrimental effect on
Ad morphogenesis.
Discussion
The role of BMI1 in stem cell maintenance (Lessard and
Sauvageau, 2003; Molofsky et al., 2003) and cancer development
(van Lohuizen et al., 1991) is well established. As a member of the
polycomb complex 1, BMI1 is important in the stable maintenance
of gene suppression, following the initiation of gene suppression
by the polycomb complex 2 (Simon and Kingston, 2009). A stable
maintenance of gene suppression plays a crucial role in inheri-
tance of cell identify during successive cell divisions.
Our ﬁndings suggest that BMI1-related HDAC activity can
inhibit Ad particle maturation. By either enforcing BMI1 expres-
sion or down-regulation of endogenous BMI1 expression, we
demonstrated an inverse correlation between the Ad progeny
production and the levels of BMI1 expression. This effect was
not related to the cell cycle status and the receptor dependent Ad
infectivity in host cells; nor to the replication of Ad genome and
the production of Ad structural proteins. Instead, BMI1 over-
expression impaired the morphogenesis of Ad particles, which
could be reversed by TSA mediated inhibition of HDAC activity.
At the morphogenesis stages in Ad infection, the association of
viral proteins with scaffolding proteins forms an empty capsid,
followed by encapsulation of viral DNA, and the degradation of
scaffolding proteins (Gustin and Imperiale, 1998; Persson et al.,
1979). Our ﬁndings suggest that BMI1-dependent HDAC activity is
critically involved in morphogenesis stages of Ad. Although the
exact action of BMI1 on Ad morphogenesis remains to be deter-
mined, it can be speculated that BMI1 plays a critical role in the
condensation of Ad core or the packaging of the Ad core into
capsid. Ad DNA is chromatinized with histone-like core proteins V
and VII (Corden et al., 1976; Fedor and Daniell, 1980; Sung et al.,
1977; Vayda and Flint, 1987). Protein VII normally exists as pre-
protein VII in the complexes of Ad core; but during the ﬁnal
maturation step of Ad virion the precursor is cleaved into core
protein VII. It is known that protein V and pre-protein VII are
acetylated (Fedor and Daniell, 1980). Thus, BMI1-related HDAC
activity may affect the acetylation of these proteins, and conse-
quently change the condensation of Ad core, resulting in distorted
virion morphology and abnormal maturation. Alternatively, BMI1
can be recruited to the site of DNA breaks and may play a crucial
role in the repair of DNA double-strand breaks (Ginjala et al.,
2011). Ad infection induces strong DNA-damage responses in host
cells (Turnell and Grand, 2012). However, these responses are
suppressed by Ad E1b55K, E4orf3 and E4orf6 proteins (Carson et
al., 2009; Stracker et al., 2002). BMI1 may potentiate DNA-damage
responses during Ad infection and thereby impair Ad progeny
production.
Further, BMI1 can be a transcriptional target of HDAC activity
(Bommi et al., 2010). It can also be a member of protein complexes
with HDAC activity (van der Vlag and Otte, 1999). Further inves-
tigation will be required to clarify the mechanisms for the
association between BMI1 overexpression and HDAC activity. The
inverse relationship between BMI1 expression and Ad progeny
production can potentially contribute to the tropism of Ad infec-
tion. It can be speculated that certain cell types although can be
successfully infected by Ad, but due to BMI1-dependent inhibition
of Ad morphogenesis, the formation of mature virion particles is
impaired. Consequently, the propagation of Ad infection is
impaired in such cell types. Ads are commonly engineered as
oncolytic agents for anti-cancer therapy. Besides other limitations,
oncolytic Ads are limited in their spreading capacity (Rebetz et al.,
2009), although high doses of oncolytic Ads have frequently
been applied. BMI1 is broadly overexpressed in various cancers,
particularly in cancer cells with stem cell properties (Lessard and
Sauvageau, 2003). Our ﬁndings indicate overexpression of BMI1 as
a limiting factor for oncolytic Ads based therapies. So inhibition of
BMI1 expression or BMI1-related HDAC activity may improve the
functionality of oncolytic Ads in targeted therapies.
Materials and methods
Adenoviral vector generation and titration
The adenoviral vector Ad5F35-PGKp-mBmi1-IRES-GFP (hereafter
referred to as BIG) was generated based on a replication-deﬁcient
Ad5F35 vector using the modiﬁed AdEasy system (Nilsson et al.,
2004). Brieﬂy, the plasmid pShuttle-PGKp-mBmi1-IRES-GFP which
carries a bicistronic expression cassette encoding murine Bmi1 cDNA
and GFP controlled by the murine phosphoglycerate kinase 1 (PGK)
gene promoter and the rabbit β-globin gene intervening sequence 2
(IVS 2) and polyadenylation, was generated from the plasmid pBMN-
mBmi1-IRES-GFP (Jaras et al., 2007). This construct was recombined
with pAdEasy-1/F35 in Escherichia coli BJ5183. Recombinant viruses
were rescued in 293 cells according to standard procedures.
The generation of Ad5F35-PGKp-ΔLNGFR-IRES-GFP (LIG),
Ad5F35-ΔLNGFR-BiDp-GFP, Ad5-PGK-GFP, Ad5F35-PGK-GFP and
Ad5-hTERT-E1A-GFP (Ad5-CRAD) vectors have been described
previously (Na and Fan, 2010). In Ad5-CRAD, the expression of
E1A is controlled by the human telomerase reverse transcriptase
(hTERT) promoter, which is preferentially active in most tumor
cells (Edqvist et al., 2006). All adenoviruses were expanded by
super-infection of 293 cells and puriﬁed by two-step CsCl cen-
trifugation. The content of physical viral particles was measured at
OD260 following sodium dodecyl sulfate mediated disruption of
viral particles according to (Mittereder et al., 1996). The content of
GFP infectious units (GIU) was assessed by ﬂow cytometric
analysis according to (Hitt et al., 2000).
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Cell culture
The human HEK 293 cells and cancer cell lines A549 (lung
epithelial carcinoma) were purchased from the American Type
Culture Collection (ATCC) and grown in Dulbecco's modiﬁed Eagle
medium (DMEM) supplemented with 10% fetal calf serum (FCS),
100 U/ml penicillin and 100 mg/ml streptomycin. 293 cells were
treated for at least 2 weeks with 50 ng/ml trichostatin A (TSA,
Sigma), or 10 μM 5-Aza-20-deoxycytidine (5-AZa, Sigma) or 60 μM
Zebularine (Sigma) before assessing the effect of BMI1-dependent
inhibition of adenoviral progeny production.
Flow cytometric analysis
The infected cells were harvested at indicated days post-infec-
tion, resuspended in PBS containing 1 mg/ml 7-aminoactinomycin D
(7-AAD, Sigma), and the extent of GFP expression was evaluated in
ﬂow cytometry. The detection of CAR, CD46, ﬁber and ΔLNGFR
expression was performed as described in our previous studies (Na
and Fan, 2010; Rebetz et al., 2009). Hexon intracellular staining was
performed with an anti-hexon monoclonal antibody (MAB8052)
and BD Cytoﬁx/Cytoperm™ Fixation/Permeabilization Solution kit
(BD Bioscience Pharmingen). BrdU-mediated cell cycle analysis was
performed in accordance with BD Pharmingen™ APC BrdU ﬂow kit
(BD Bioscience Pharmingen). Cells were cultured with BrdU at
10 μM for 1 h.
Retroviral constructs and infection
The retroviral constructs for pBabe-puro/BMI1, pBabe-puro-GFP,
pSuper-retro/siBMI1 and pSuper-retro-siGFP were kindly provided
by Dr. Han-Fei Ding (Cui et al., 2006). The VSV-G pseudotyped
retrovirus Retro-BMI1, Retro-GFP, Retro-siBMI1 and Retro-siGFP
were generated by calcium phosphate mediated transient co-
transfection of backbone plasmid with VSVG and Gag-pol plasmids
in phoenix-GP cells. The titration of viral preparation was per-
formed in HT1080 cells by ﬂow cytometric analysis. Following
retroviral vector infection, A549 cells were selected by puromycin
for at least one week. The new cell lines A549-BMI1 (BMI1 over-
expression A549), A549-GFP (GFP overexpression A549), A549-
siBMI1 (BMI1 knockdown A549), and A549-siGFP (GFP knockdown
A549) were created after puromycin selection.
Cell proliferation assay
A549-siBMI1 and A549-siGFP cells were seeded at 1103 cells/
well into 96-well plates. The number of viable cells was measured
every 2 days and 4 wells were chosen each time. The grow rate of
cells was evaluated using the CellTiter 96s AQueous Non-
Radioactive Cell Proliferation Assay kit (Promega) according to
the manufacturer's instructions. Brieﬂy, twenty microliters MTS
solution were added into each well containing 100 μl medium.
Following incubation at 37 1C for 2 h, the absorbance at 490 nm
was measured.
Real-time RT-PCR analysis
A549-siBMI1 or A549-siGFP cells were infected with Ad5-CRAD
virus at 200 OPU/cell. After 24 h post infection, Total mRNA from
infected A549-siBMI1 or A549-siGFP cells was extracted and
puriﬁed using RNAeasy kit (Qiagen) in accordance with the
manufacture's protocol. Aliquots of 20 μl cDNA was synthesized
using 1 μg total mRNA within SuperScript First-Strand Synthesis
System (Life Technologies) according to the manufacturer's
instructions. The Lightcycler Faststart DNA MasterPlus SYBR Green
I kit (Roche) was used for real-time PCR assessment of the mRNA
expression of BMI1, E1A, 100 K and hexon protein on a Lightcycler
2.0 real-time PCR system (Roche). The primers used were as
follows:
BMI-1 forward: 50-ATGGCCGCTTGGCTCGCATT-30
BMI-1 reverse: 50-AGCACACACATCAGGTGGGGA-30
E1A forward: 50-TCTGCCACGGAGGTGTTATT-30
E1A reverse: 5-0TTCCTGCACCGCCAACATTA-30
Ad5 100 K forward: 50-CCTACCCGCAGTTGGCGACG -30
Ad5 100 K reverse: 50-ACGGTAACGAGCACTGCGGC-30
Hexon forward: 50-GGCCTACCCTGCTAACTTCC-30
Hexon reverse: 50-TGGCGTAGAGAAGGTTTTGG-30
GAPDH forward: 50-CCCTGTTGCTGTAGCCAAATTC-30
GAPDH reverse: 50-TCTCCTCTGACTTCAACAGCGAC-30
Western blot analysis
293 cells were infected with BIG or LIG virus, and harvested at
the manifestation of cytopathic effect, washed with cold PBS and
lysed in cell lysis buffer with a cocktail of protease inhibitors
(Sigma, p-2714) for 30 min on ice. Aliquots of 40 μg total proteins
of lysed cells were separated with SDS-PAGE and transferred to
PVDF membrane. The membrane was blocked with 3% BSA and
0.5% goat serum, and incubated with 1.0 mg/ml 4D2 anti-ﬁber MAb
at 4 1C overnight. Subsequently, the membrane was washed with
PBS and incubated with goat anti-mouse IgG-HPR and visualized
with Opti-4CN™ substrate kit (BIO-RAD). Staining with penton
base antibody (a gift from Dr. Pierre Boulanger) and hexon anti-
body (MAB8052, Millipore) was performed in a similar manner.
Quantiﬁcation of produced progeny viruses
A549-siBMI1 or A549-siGFP cells were seeded at 1.5105 cells/
well in 12-well plates. Cells were infected with Ad at 100 or
200 OPU/cell and washed at 4 h post-infection to remove unbound
viruses. At 24 h post-infection, cells were harvested for Ad genome
quantiﬁcation or re-infection assay. For Ad genome quantiﬁcation,
cell digestion and DNA extraction were performed according to
(Garnett et al., 2009). DNA samples from infected cells were
diluted and run on a Lightcycler 2.0 using the Lightcycler Faststart
DNA MasterPlus SYBR Green I kit (Roche). Primers located near the
far right end of Ad5 genome for detection of complete genomes
were used as described in the study by (Thomas et al., 2007). The
forward primer (50-CAGCGTAGCCCCGATGTAA-3″) corresponded to
base pairs 34,974–34,955 of Ad5 genome, and the reverse primer
(50-TTTTTGAGCAGCACCTTGCA-3″) corresponded to base pairs
34,955–34,974. The qPCR results were analyzed in the REST 2009
program (Pfafﬂ, 2001). For re-infection assay, cells were frozen/
thawed three times to release viruses. The supernatant was used
to re-infect new A549 cells. At 24 h post re-infection, the percen-
tages of GFP expressing cells were analyzed by ﬂow cytometry.
To further assess the production of progeny viral genome,
episomal DNA samples in the infected cells at the manifestation
of cytopathic effect were extracted with DNeasy Blood & Tissue kit
(Qiagen), digested with HindIII, separated in 0.8% agarose gel and
photographed.
Electron microscopy studies
CsCl-banded viral stocks were thawed and diluted to 11011
optical particle units per milliliter (OPU/ml) with ultrapure H2O.
The virus suspensions were adsorbed onto glow discharged carbon
coated copper grids for 2 min. Grids were then washed brieﬂy
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with ultrapure H2O, ﬁxed in 2% glutaraldehyde diluted in 0.1 M
NaCac buffer (pH 7.4), and stained with 0.75% uranyl formate. Viral
particles were analyzed in 25 to 35 randomly selected ﬁelds in
each grid.
To assess Ad morphogenesis in situ, 293 cells with or without
pre-treatment with TSA were infected for 24 h with T-BIG pre-
paration (the BIG vector preparation expanded in 293 cells pre-
treated with TSA) at 200 OPU/cell. Cells were harvested and ﬁxed
in 2% glutaraldehyde diluted in 0.1 M NaCac buffer (pH 7.4) for
12 h, rinsed in NaCac and then treated with 1% osmium tetroxid
(also diluted in 0.1 M NaCac buffer at pH 7.4) for 2 h. Pellets were
then dehydrated and embedded in Agar 100 resin. Ultrathin
sections (50 nm) were prepared and placed on glow discharged
carbon coated copper grids. The sections were then stained with
2% uranylacetate and lead citrate. Samples were observed in a Jeol
JEM 1230 electron microscope, operated at 80 kV of accelerating
voltage. A total of 50 cells were analyzed for virus particles.
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